search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Screening op hersenmetastasen bij niet kleincellig longkanker: de psychologische impact van de diagnose asymptomatische hersenmetastasen; een focus groep onderzoek


- candidate number29360
- NTR NumberNTR7417
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR2-aug-2018
- Secondary IDsMETC 2017-0286 
- Public TitleScreening op hersenmetastasen bij niet kleincellig longkanker: de psychologische impact van de diagnose asymptomatische hersenmetastasen; een focus groep onderzoek
- Scientific TitleScreening for brain metastases in lung cancer: the psychological impact of being diagnosed with asymptomatic brain metastases, a qualitative study
- ACRONYM
- hypothesis
- Healt Condition(s) or Problem(s) studiedLung cancer, Non small cell lung cancer (NSCLC), Brain metastasis, Psychological impact
- Inclusion criteria- Stage IV lung cancer patients diagnosed with asymptomatic brain metastases detected by screening
- Stage IV lung cancer patients who were diagnosed in the past with asymptomatic brain metastases
- systemic treatment is allowed
or
- partners of stage IV lung cancer patient with asymptomatic brain metastases
- Exclusion criteria- Inability to interact in focus groups
- Other neurologic illness (such as Alzheimer's disease)
- mec approval receivedyes
- multicenter trialno
- randomisedno
- group[default]
- Type[default]
- Studytypeobservational
- planned startdate 1-mrt-2018
- planned closingdate1-jul-2019
- Target number of participants18
- InterventionsFocus group (no real intervention)
- Primary outcomeTo explore the psychological impact of being diagnosed with asymptomatic brain metastases for both the patients and their partners
- Secondary outcomeNot applicable
- Timepoints6 focusgroups within a year.
Analyzing 6 months.
Year after last focus group, publication.
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES L. Hendriks
- CONTACT for SCIENTIFIC QUERIES L. Hendriks
- Sponsor/Initiator Maastricht University Medical Center (MUMC+)
- Funding
(Source(s) of Monetary or Material Support)
Roche
- Publications
- Brief summary
- Main changes (audit trail)
- RECORD2-aug-2018 - 15-aug-2018


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl